NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

By S. Chitturi, S. Abeygunasekera, G. Farrell, J. Holmes-Walker, J. Hui, C. Fung, R. Karim, R. Lin, D. Samarasinghe, C. Liddle and 2 more. Hepatology, 2002

1,163 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/7f51cb900e2c159002177975d7535268b07dda07

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Michelle M. Wiest
2. Amalia Gastaldelli
3. A. Sanyal
4. E. Bugianesi
5. E. Ferrannini

In Epidemiology

1. A. Sanyal
2. E. Bugianesi
3. Michelle M. Wiest
4. Amalia Gastaldelli
5. E. Ferrannini
6. B. Neuschwander‐Tetri

In Hepatology

1. A. Sanyal

Citations in the corpus

• The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease (2006, background): “A recent study (19) reported a higher prevalence of the metabolic syndrome in patients with nonalcoholic steatohepatitis than in patients with hepatitis C who had comparable fibrosis.”
• The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. (2003, neutral): “NASH, which is often associated with obese individuals and patients with insulin resistance and type 2 diabetes, is an important feature of metabolic syndromes (1, 39).”
• Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005, background): “In large population studies, nearly all of the NAFLD patients examined were insulin resistant according to the homeostasis model assessment [11, 12].”
• A lipidomic analysis of nonalcoholic fatty liver disease (2007, methodology): “10,11 On the basis of the liver histology, 3 groups were studied: (1) normal histology controls, (2) NAFL, and (3) NASH.”